Myovant Sciences Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
27.00
|
|
Average Rating
|
3.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.49
|
-0.47
|
0.02
|
4.08%
|
|
2022-06-30
|
-0.32
|
-0.22
|
0.10
|
31.25%
|
|
2022-03-31
|
-0.57
|
-0.63
|
-0.06
|
-10.53%
|
|
2021-12-31
|
-0.61
|
-0.68
|
-0.07
|
-11.48%
|
|
2021-09-30
|
-0.38
|
-0.23
|
0.15
|
39.47%
|
|
2021-06-30
|
-0.34
|
-0.67
|
-0.33
|
-97.06%
|
|
2021-03-31
|
-0.99
|
-0.89
|
0.10
|
10.10%
|
|
2020-12-31
|
-0.85
|
-0.82
|
0.03
|
3.53%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.69
|
|
2022-03-31
|
-2.21
|
|
2021-03-31
|
-2.83
|
|
2020-03-31
|
-3.37
|
|
2019-03-31
|
-4.08
|
|
2018-03-31
|
-2.40
|
|
2017-03-31
|
-1.32
|